Search Details

Word: tumorous (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...FastPack As if undergoing treatment for prostate cancer weren't bad enough, men usually have to wait up to a week for blood tests to determine whether or not their tumor has returned. In June the FDA approved FastPack, an automated blood analyzer designed by Qualigen of Carlsbad, Calif., that measures in as little as 15 minutes the level of prostate-specific antigen found in a blood sample. The FDA concluded, however, that there weren't enough data to approve FastPack as a screening tool for the general population as well...

Author: /time Magazine | Title: Your A to Z Guide to the Year in Medicine | 1/6/2001 | See Source »

...were pleased that the PRS 400, our miniature X-ray source, was included in your Inventions 2000 report, but we want to clarify one point for your readers. Our device is a valuable tool for radiation treatment given in the operating room at the time of tumor removal and for the treatment of brain tumors for which radiation is used instead of surgery. At the present time, it is not a replacement for standard radiation therapy or chemotherapy. Clinical trials are under way, however, that could prove that treatment during surgery using our device may be the only therapy needed...

Author: /time Magazine | Title: Letters: Dec. 25, 2000 | 12/25/2000 | See Source »

...first and most famous of these are Wyeth-Ayerst’s Enbrel, and Remicade, manufactured by a subsidiary of Johnson and Johnson, which have been in use now for roughly two years. Both Enbrel and Remicade inhibit a key messenger in the inflammatory cascade known as the tumor necrosis factor (TNF). The drugs are both more effective than traditional medications, and more likely to slow down joint degradation. "The idea that biologics could prove effective against autoimmune diseases has been firmly established by the TNF story," says Dr. H. Michael Belmont of the Hospital for Joint Diseases in New York...

Author: /time Magazine | Title: Immune System Disorders | 12/18/2000 | See Source »

Other antibodies carry tiny payloads of radioactive isotopes or poisons, which kill the tumor cell without affecting surrounding tissue. IDEC Pharmaceuticals, in San Diego, just completed final rounds of testing Zevalin, an antibody that is hooked to the radioactive isotope, yttrium-90. Last month, IDEC reported that the tumors in about one third of 73 late-stage non-Hodgkins lymphoma patients were undetectable after being treated with Zevalin...

Author: /time Magazine | Title: A Virus That Kills Cancer | 12/18/2000 | See Source »

Folkman's laboratory at Children's Hospital has also developed Angiostatin and thalidomide--two drugs other than 2ME2 and Endostatin that also disrupt blood flow to tumor cells...

Author: By Keith J. Lo, CONTRIBUTING WRITER | Title: Anti-Cancer Drug Advances to Human Testing | 12/8/2000 | See Source »

Previous | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | Next